
LYME DISEASE AND HBOT
According to the CDC, Lyme disease is the most common vector-borne disease in the United States. There are over 300,000 cases reported each year.
LYME DISEASE & HYPERBARICS
According to the Centers for Disease Control and Prevention (CDC), Lyme disease is the most prevalent vector-borne illness in the United States, with an estimated 300,000 cases reported annually.
Lyme disease can be challenging to identify and diagnose, making it difficult to determine the true number of individuals affected. According to the CDC, common symptoms include fever, headache, fatigue, and a distinctive skin rash. If left untreated, the infection can progress and potentially spread to the joints, heart, and nervous system.
The bacteria responsible for Lyme disease—a tick-borne spirochete—can shield itself within a protective biofilm, allowing it to evade the immune system and potentially remain dormant for extended periods. As a result, antibiotic treatment alone may not always provide lasting relief. However, when used alongside conventional therapies, hyperbaric oxygen therapy (HBOT) may offer significant additional benefits.
HBOT enhances the body's oxygen levels by delivering 100% oxygen at increased atmospheric pressure. This environment can help weaken or eliminate the Lyme bacteria, reduce inflammation, and strengthen immune response. As an adjunctive therapy, HBOT shows promise in managing chronic Lyme disease, particularly in addressing persistent symptoms and neurological complications.

HOW HBOT CAN HELP
Ameliorate Neurological Conditions With HBOT
-
Decreases neuroinflammation
-
Enhances short-term memory
-
Reduces chronic fatigue
-
Ameliorates chronic headaches
-
Lessens depression
-
Moderates insomnia
-
Improves concentration
Increase Mobility With HBOT
-
Diminishes inflammatory-related arthritic pain
-
Lessens muscle discomfort
-
Improves walking distance
-
Amplifies energy levels
Hyperbarics for Chronic Lyme
-
Induces angiogenesis to mobilize blood flow to affected tissue and bone
-
Augments antibiotic interventions by driving spirochete out of biofilms
-
Enhances white blood cell and immune system activity
-
Augments antibiotic interventions by driving spirochete out of biofilms
-
Increases oxygen free radicals to combat the bacterial organism
-
Improves antibiotic cell wall penetration
Dr. Jason Sonners of HBOT USA discusses the benefits of HBOT with Lyme.
REFERENCES
International Hyperbarics Association. (2019). Lyme Disease & Hyperbarics [Brochure]. International Hyperbarics Association.
Lyme disease home | CDC. (2022, January 19). Centers for Disease Control and Prevention. https://www.cdc.gov/lyme/index.html